Antibacterial therapeutic drug monitoring in cerebrospinal fluid: Difficulty in achieving adequate drug concentrations ; Case report

Journal of Neurosurgery

Volumn 118, Issue 2, 2013, Pages 297-301

  Lonsdale, Dagan O ^a   Udy, Andrew A ^a,b   Roberts, Jason A ^a,b   Lipman, Jeffrey ^a,b  

^a ROYAL BRISBANE AND WOMEN'S HOSPITAL   (Australia)

^b UNIVERSITY OF QUEENSLAND   (Australia)

Author keywords

Cerebrospinal fluid; Infection; Subarachnoid hemorrhage; Therapeutic drug monitoring

Indexed keywords

CREATININE; INFUSION FLUID; MEROPENEM; VANCOMYCIN;

ADULT; ANEURYSM RUPTURE; ANTERIOR COMMUNICATING ARTERY ANEURYSM; ANTIMICROBIAL THERAPY; ARTICLE; BACTERIAL GROWTH; BRAIN HEMORRHAGE; BRAIN VENTRICULITIS; CASE REPORT; CEREBROSPINAL FLUID; COMPUTER ASSISTED TOMOGRAPHY; CONTINUOUS INFUSION; CRANIOTOMY; CREATININE BLOOD LEVEL; CREATININE CLEARANCE; CRITICALLY ILL PATIENT; DRUG CONCENTRATION; DRUG DOSE INCREASE; DRUG EXPOSURE; DRUG MONITORING; DRUG WITHDRAWAL; FLUID THERAPY; FRONTAL LOBE; HEMATOMA; HOSPITAL DISCHARGE; HUMAN; INTENSIVE CARE; KIDNEY CLEARANCE; KLEBSIELLA PNEUMONIAE; LOADING DRUG DOSE; MALE; MINIMUM INHIBITORY CONCENTRATION; OBSTRUCTIVE HYDROCEPHALUS; PHARMACOKINETICS; PRESCRIPTION; PRIORITY JOURNAL; STAPHYLOCOCCUS EPIDERMIDIS; SUBARACHNOID HEMORRHAGE; TREATMENT DURATION;

ADULT; ANTI-BACTERIAL AGENTS; CEREBRAL VENTRICULITIS; DRUG MONITORING; DRUG THERAPY, COMBINATION; HUMANS; HYDROCEPHALUS; MALE; SUBARACHNOID HEMORRHAGE; THIENAMYCINS; VANCOMYCIN; VENTRICULOSTOMY;

EID: 84873645470     PISSN: 00223085     EISSN: 19330693     Source Type: Journal    
DOI: 10.3171/2012.10.JNS12883     Document Type: Article

References (32)

1. Baptista JP, Sousa E, Martins PJ, Pimentel JM: Augmented renal clearance in septic patients and implications for vancomycin optimisation. Int J Antimicrob Agents 39:420-423, 2012.
2. Baptista JP, Udy AA, Sousa E, Pimentel J, Wang L, Roberts JA, et al: A comparison of estimates of glomerular filtration in critically ill patients with augmented renal clearance. Crit Care 15:R139, 2011.
3. Beer R, Lackner P, Pfausler B, Schmutzhard E: Nosocomial ventriculitis and meningitis in neurocritical care patients. J Neurol 255:1617-1624, 2008.
4. Beer R, Pfausler B, Schmutzhard E: Infectious intracranial complications in the neuro-ICU patient population. Curr Opin Crit Care 16:117-122, 2010.
5. Craig WA: Pharmacokinetic/pharmacodynamic parameters: rationale for antibacterial dosing of mice and men. Clin Infect Dis 26:1-12, 1998.
6. Di Giantomasso D, May CN, Bellomo R: Norepinephrine and vital organ blood flow. Intensive Care Med 28:1804-1809, 2002.
7. Di Giantomasso D, May CN, Bellomo R: Vital organ blood flow during hyperdynamic sepsis. Chest 124:1053-1059, 2003.
8. Jeffres MN, Isakow W, Doherty JA, McKinnon PS, Ritchie DJ, Micek ST, et al: Predictors of mortality for methicillinresistant Staphylococcus aureus health-care-associated pneumonia: specific evaluation of vancomycin pharmacokinetic indices. Chest 130:947-955, 2006.
9. Kees MG, Hilpert JW, Gnewuch C, Kees F, Voegeler S: Clearance of vancomycin during continuous infusion in Intensive Care Unit patients: correlation with measured and estimated creatinine clearance and serum cystatin C. Int J Antimicrob Agents 36:545-548, 2010.
10. Kumar A, Roberts D, Wood KE, Light B, Parrillo JE, Sharma S, et al: Duration of hypotension before initiation of effective antimicrobial therapy is the critical determinant of survival in human septic shock. Crit Care Med 34:1589-1596, 2006.
11. Lozier AP, Sciacca RR, Romagnoli MF, Connolly ES Jr: Ventriculostomy- related infections: a critical review of the literature. Neurosurgery 51:170-182, 2002.
12. McKinnon PS, Paladino JA, Schentag JJ: Evaluation of area under the inhibitory curve (AUIC) and time above the minimum inhibitory concentration (T>MIC) as predictors of outcome for cefepime and ceftazidime in serious bacterial infections. Int J Antimicrob Agents 31:345-351, 2008.
13. McWhinney BC, Wallis SC, Hillister T, Roberts JA, Lipman J, Ungerer JP: Analysis of 12 beta-lactam antibiotics in human plasma by HPLC with ultraviolet detection. J Chromatogr B Analyt Technol Biomed Life Sci 878:2039-2043, 2010.
14. Moise-Broder PA, Forrest A, Birmingham MC, Schentag JJ: Pharmacodynamics of vancomycin and other antimicrobials in patients with Staphylococcus aureus lower respiratory tract infections. Clin Pharmacokinet 43:925-942, 2004.
15. Nau R, Sörgel F, Eiffert H: Penetration of drugs through the blood-cerebrospinal fluid/blood-brain barrier for treatment of central nervous system infections. Clin Microbiol Rev 23: 858-883, 2010.
16. Pujal M, Soy D, Codina C, Ribas J: Are higher vancomycin doses needed in ventricle-external shunted patients? Pharm World Sci 28:215-221, 2006.
17. Ricard JD, Wolff M, Lacherade JC, Mourvillier B, Hidri N, Barnaud G, et al: Levels of vancomycin in cerebrospinal fluid of adult patients receiving adjunctive corticosteroids to treat pneumococcal meningitis: a prospective multicenter observational study. Clin Infect Dis 44:250-255, 2007.
18. Roberts JA, Kruger P, Paterson DL, Lipman J: Antibiotic resistance- what's dosing got to do with it? Crit Care Med 36: 2433-2440, 2008.
19. Roberts JA, Lipman J: Pharmacokinetic issues for antibiotics in the critically ill patient. Crit Care Med 37:840-851, 2009.
20. Roberts JA, Norris R, Paterson DL, Martin JH: Therapeutic drug monitoring of antimicrobials. Br J Clin Pharmacol 73: 27-36, 2012.
21. Roberts JA, Taccone FS, Udy AA, Vincent JL, Jacobs F, Lipman J: Vancomycin dosing in critically ill patients: robust methods for improved continuous-infusion regimens. Antimicrob Agents Chemother 55:2704-2709, 2011.
22. Roberts JA, Ulldemolins M, Roberts MS, McWhinney B, Ungerer J, Paterson DL, et al: Therapeutic drug monitoring of beta-lactams in critically ill patients: proof of concept. Int J Antimicrob Agents 36:332-339, 2010.
23. Rybak MJ: The pharmacokinetic and pharmacodynamic properties of vancomycin. Clin Infect Dis 42 (Suppl 1):S35- S39, 2006.
24. Sen J, Belli A, Albon H, Morgan L, Petzold A, Kitchen N: Triple-H therapy in the management of aneurysmal subarachnoid haemorrhage. Lancet Neurol 2:614-621, 2003.
25. Teasdale G, Jennett B: Assessment of coma and impaired consciousness. A practical scale. Lancet 2:81-84, 1974.
26. Tunkel AR, Hartman BJ, Kaplan SL, Kaufman BA, Roos KL, Scheld WM, et al: Practice guidelines for the management of bacterial meningitis. Clin Infect Dis 39:1267-1284, 2004.
27. Udy A, Boots R, Senthuran S, Stuart J, Deans R, Lassig-Smith M, et al: Augmented creatinine clearance in traumatic brain injury. Anesth Analg 111:1505-1510, 2010.
28. Udy A, Roberts JA, Boots RJ, Lipman J: You only find what you look for: the importance of high creatinine clearance in the critically ill. Anaesth Intensive Care 37:11-13, 2009.
29. Udy AA, Roberts JA, Boots RJ, Paterson DL, Lipman J: Augmented renal clearance: implications for antibacterial dosing in the critically ill. Clin Pharmacokinet 49:1-16, 2010.
30. Udy AA, Roberts JA, Lipman J: Implications of augmented renal clearance in critically ill patients. Nat Rev Nephrol 7: 539-543, 2011.
31. Udy AA, Varghese JM, Altukroni M, Briscoe S, McWhinney BC, Ungerer JP, et al: Sub-therapeutic initial β-lactam concentrations in select critically ill patients: association between augmented renal clearance and low trough drug concentrations. Chest 142:30-39, 2012.
32. Wan L, Bellomo R, May CN: The effects of normal and hypertonic saline on regional blood flow and oxygen delivery. Anesth Analg 105:141-147, 2007.